Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients.
Scherber R, Dueck AC, Johansson P, Barbui T, Barosi G, Vannucchi AM, Passamonti F, Andreasson B, Ferarri ML, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Harrison CN, Radia D, Mesa RA. Scherber R, et al. Among authors: radia d. Blood. 2011 Jul 14;118(2):401-8. doi: 10.1182/blood-2011-01-328955. Epub 2011 May 2. Blood. 2011. PMID: 21536863 Free article.
Advanced Systemic Mastocytosis with associated haematological neoplasm: Treatment with avapritinib can facilitate successful bridge to allogeneic haematopoietic cell transplant.
Sriskandarajah P, McLornan DP, Oni C, Wilson AJ, Woodley C, Ciesielska M, Raj K, Dillon R, Ethell M, Chacko J, Orchard K, Radia DH. Sriskandarajah P, et al. Among authors: radia dh. Curr Res Transl Med. 2023 Jul-Sep;71(3):103398. doi: 10.1016/j.retram.2023.103398. Epub 2023 Jun 13. Curr Res Transl Med. 2023. PMID: 37331225
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives.
Valent P, Hartmann K, Bonadonna P, Sperr WR, Niedoszytko M, Hermine O, Kluin-Nelemans HC, Sotlar K, Hoermann G, Nedoszytko B, Broesby-Olsen S, Zanotti R, Lange M, Doubek M, Brockow K, Alvarez-Twose I, Varkonyi J, Yavuz S, Nilsson G, Radia D, Grattan C, Schwaab J, Gülen T, Oude Elberink HNG, Hägglund H, Siebenhaar F, Hadzijusufovic E, Sabato V, Mayer J, Reiter A, Orfao A, Horny HP, Triggiani M, Arock M. Valent P, et al. Among authors: radia d. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1706-1717. doi: 10.1016/j.jaip.2023.02.021. Epub 2023 Mar 1. J Allergy Clin Immunol Pract. 2023. PMID: 36868470 Free article. Review.
Mastocytosis demystified.
Veitch S, Radia DH. Veitch S, et al. Among authors: radia dh. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):396-406. doi: 10.1182/hematology.2023000505. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066855 Free PMC article. Review.
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.
Valent P, Hoermann G, Bonadonna P, Hartmann K, Sperr WR, Broesby-Olsen S, Brockow K, Niedoszytko M, Hermine O, Chantran Y, Butterfield JH, Greiner G, Carter MC, Sabato V, Radia DH, Siebenhaar F, Triggiani M, Gülen T, Alvarez-Twose I, Staudinger T, Traby L, Sotlar K, Reiter A, Horny HP, Orfao A, Galli SJ, Schwartz LB, Lyons JJ, Gotlib J, Metcalfe DD, Arock M, Akin C. Valent P, et al. Among authors: radia dh. J Allergy Clin Immunol Pract. 2023 Oct;11(10):3010-3020. doi: 10.1016/j.jaip.2023.08.008. Epub 2023 Aug 10. J Allergy Clin Immunol Pract. 2023. PMID: 37572755 Free article. Review.
The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis.
Mesa RA, Schwager S, Radia D, Cheville A, Hussein K, Niblack J, Pardanani AD, Steensma DP, Litzow MR, Rivera CE, Camoriano J, Verstovsek S, Sloan J, Harrison C, Kantarjian H, Tefferi A. Mesa RA, et al. Among authors: radia d. Leuk Res. 2009 Sep;33(9):1199-203. doi: 10.1016/j.leukres.2009.01.035. Epub 2009 Feb 27. Leuk Res. 2009. PMID: 19250674 Free PMC article.
Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients.
Gowin K, Thapaliya P, Samuelson J, Harrison C, Radia D, Andreasson B, Mascarenhas J, Rambaldi A, Barbui T, Rea CJ, Camoriano J, Gentry A, Kiladjian JJ, O'Connell C, Mesa R. Gowin K, et al. Among authors: radia d. Haematologica. 2012 Oct;97(10):1570-3. doi: 10.3324/haematol.2011.061390. Epub 2012 Mar 14. Haematologica. 2012. PMID: 22419578 Free PMC article.
97 results